The FDA has approved Dupixent (dupilumab) for the treatment of adult and pediatric patients aged 6 years and older with allergic fungal rhinosinusitis.

Addressing modifiable household exposures may help improve outcomes for adults with asthma, according to a recent study.

The FDA's chief says the agency will begin offering bonuses to drug reviewers who complete their work ahead of schedule.

For children with severe OSA undergoing adenotonsillectomy, postoperative respiratory volume monitoring is feasible and can predict low minute ventilation.

Cirrhosis, malignancy, and acute kidney injury are among the clinical factors associated with early mortality in patients with septic shock.